TrialScientific reports2025

Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.